These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


485 related items for PubMed ID: 29733849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
    Jin YH, Li ZT, Chen H, Jiang XQ, Zhang YY, Wu F.
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
    Yao Y, Hu X, Feng X, Zhao Y, Song M, Wang C, Fan H.
    J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [β1 receptor blocker decreases the myocardial inflammation in the sepsis adult rats through inhibition of TLR4/NF-ΚB signaling pathway].
    Liu X, Wen M, Li X, Chen L, Zeng J, Deng Y, Zeng H.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb; 31(2):193-197. PubMed ID: 30827308
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L, Li L, Lu S, Li K, Su Z, Wang Y, Fan X, Li X, Zhao G.
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [Abstract] [Full Text] [Related]

  • 9. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
    Xue BB, Chen BH, Tang YN, Weng CW, Lin LN.
    Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
    [Abstract] [Full Text] [Related]

  • 10. Dexmedetomidine Inhibits TLR4/NF-κB Activation and Reduces Acute Kidney Injury after Orthotopic Autologous Liver Transplantation in Rats.
    Yao H, Chi X, Jin Y, Wang Y, Huang P, Wu S, Xia Z, Cai J.
    Sci Rep; 2015 Nov 20; 5():16849. PubMed ID: 26585410
    [Abstract] [Full Text] [Related]

  • 11. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
    Hsing CH, Lin CF, So E, Sun DP, Chen TC, Li CF, Yeh CH.
    Am J Physiol Renal Physiol; 2012 Nov 15; 303(10):F1443-53. PubMed ID: 22933299
    [Abstract] [Full Text] [Related]

  • 12. β-Casomorphin-7 Ameliorates Sepsis-Induced Acute Kidney Injury by Targeting NF-κB Pathway.
    Zhang Z, Zhao H, Ge D, Wang S, Qi B.
    Med Sci Monit; 2019 Jan 05; 25():121-127. PubMed ID: 30610183
    [Abstract] [Full Text] [Related]

  • 13. Dexmedetomidine Ameliorate CLP-Induced Rat Intestinal Injury via Inhibition of Inflammation.
    Chen Y, Miao L, Yao Y, Wu W, Wu X, Gong C, Qiu L, Chen J.
    Mediators Inflamm; 2015 Jan 05; 2015():918361. PubMed ID: 26273145
    [Abstract] [Full Text] [Related]

  • 14. [Protective effects of microRNA-181b on aged rats with sepsis-induced hippocampus injury in vivo].
    Dong R, Hu D, Li Q, Xu T, Sui Y, Qu Y.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul 05; 31(7):857-861. PubMed ID: 31441410
    [Abstract] [Full Text] [Related]

  • 15. Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis.
    Yu M, Shao D, Liu J, Zhu J, Zhang Z, Xu J.
    Int Immunopharmacol; 2007 Aug 05; 7(8):1076-82. PubMed ID: 17570324
    [Abstract] [Full Text] [Related]

  • 16. The effect of dexmedetomidine on inflammatory response of septic rats.
    Zhang J, Wang Z, Wang Y, Zhou G, Li H.
    BMC Anesthesiol; 2015 May 01; 15():68. PubMed ID: 25929655
    [Abstract] [Full Text] [Related]

  • 17. Dexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4/NF-κB pathway.
    Wu Y, Liu Y, Huang H, Zhu Y, Zhang Y, Lu F, Zhou C, Huang L, Li X, Zhou C.
    Mediators Inflamm; 2013 May 01; 2013():562154. PubMed ID: 23690665
    [Abstract] [Full Text] [Related]

  • 18. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
    Zhang JJ, Peng K, Zhang J, Meng XW, Ji FH.
    PLoS One; 2017 May 01; 12(2):e0172006. PubMed ID: 28222157
    [Abstract] [Full Text] [Related]

  • 19. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Zhai Y, Zhu Y, Liu J, Xie K, Yu J, Yu L, Deng H.
    Med Sci Monit; 2020 Jan 08; 26():e918617. PubMed ID: 31912804
    [Abstract] [Full Text] [Related]

  • 20. [Sivelestat protects acute kidney injury by inhibiting the PI3K/AKT pathway in septic rats].
    Ding Q, Wang Y, Yang C, Dilireba T, Li X, Yu X.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar 08; 35(3):256-262. PubMed ID: 36916337
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.